Early disclosure of AD blood biomarker results increases diagnostic certainty and leads to earlier, more targeted clinical ...

A large global study provides new evidence supporting the use of blood biomarkers in an Alzheimer's clinical trial to screen for elevated brain amyloid levels among potential participants who are ...

On average, reduction in plasma neurofilament light levels was observed during the first 12 weeks of treatment, with a greater decline in participants with baseline levels at or above the median ...

Nektar Therapeutics (Nasdaq: NKTR) and collaborators at the Icahn School of Medicine at Mount Sinai today announced new ...

Everest Biolabs has been awarded a $2.1 million Small Business Innovation Research grant from the National Institute of ...

Emerging discoveries in liquid biomarker research promise to transform early detection, diagnosis, and treatment monitoring ...

Biomarker profiles are tumor-specific and can predict sensitivity or resistance to targeted therapy or immune checkpoint inhibition, enabling more individualized treatment selection than histology ...